Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
CRO
Syneos Health scoops up Chinese CRO
Bestudy will work as a standalone company with its own leadership, brand and local operating model, under the Syneos umbrella.
Darren Incorvaia
Mar 19, 2026 11:00am
Fierce Pharma
Servier rounds out rare cancer offerings with $2.5B Day One buy
Mar 6, 2026 10:14am
Asahi Kasei to buy Germany's Aicuris for $920M
Feb 26, 2026 2:00am
Werewolf weighs sale or merger as cash reserves whimper
Feb 24, 2026 5:23pm
Qiagen 'open for discussion' on shareholder value
Feb 6, 2026 9:15am
Medtronic steps up with CathWorks buyout
Feb 4, 2026 9:15am
